Fig. 8
From: DLGAP5 promotes lung adenocarcinoma growth via upregulating PLK1 and serves as a therapeutic target
Prognostic value of DLGAP5 expression in patients with LUAD. A–C The prognostic value of DLGAP5 expression in OS (A), DSS (B) and PFI (C) of all patients with LUAD. D–L The prognostic value of DLGAP5 expression in different subgroups, including T2 stage (D), T3&T4 stage (E), M0 stage (F), Age ≤ 65 (G), Age > 65 (H), Gender-female (I), Gender-male (J), Smoker (K) and Primary therapy outcome-(PR&CR&SD) (L)